On the pan-cancer level, 7/12 missense mutational cancer genes were also significant hits in at least one of the three analyses of the DepMap CRISPR screen while only TP53 was identified as a significant non-missense mutational cancer gene in the DepMap CRISPR screen. This evidence concerns the gene TP53 and cancer.